Discussion: Next, we select samples for which no mutation has been detected (to flush out
L452R and
W152C mutations), as well as samples with an isolated
E484K mutation.
Discussion: Since early May 2021, a new NovaplexSARS-CoV-2 Variants II Assay has been available on the market to detect
L452R,
K417N,
K417T and
W152C mutations.
Discussion: The other two targets of the Variant II Assay are the
L452R and
W152C mutations.